Month: October 2025
Meta wants to bring its Business AI chat tools to third-party websites
Meta CEO Mark Zuckerberg speaks as he presents the new Meta Ray-Ban Display at the 2025 Meta Connect conference in Menlo Park, California, on Sept. 17, 2025. Benjamin Legendre | AFP | Getty Images Meta‘s efforts to expand its core business from online advertising involves pitching companies AI-powered chat tools that they can use on […]
Read More
Trump touts shutdown as ‘unprecedented opportunity’ to cut more Democratic priorities
U.S. President Donald Trump gestures as he arrives on the South Lawn of the White House in Washington, D.C., U.S., Sept. 30, 2025. Ken Cedeno | Reuters President Donald Trump on Thursday said Democrats have given him an “unprecedented opportunity” to slash federal agencies, signaling plans to harm his political opponents during the two-day-old government […]
Read More
Tesla reports 497,000 vehicle deliveries for Q3, up 7%
Tesla vehicles are parked outside of a dealership on July 24, 2025 in Austin, Texas. Brandon Bell | Getty Images Tesla reported quarterly vehicle deliveries of 497,099 for the period ended Sept. 30, which coincided with the expiration of a key tax credit for buyers of electric vehicles in the U.S. Here are the key […]
Read More
Russia’s economy is creaking — and the Kremlin wants Russians to pay more for the war
Russian President Vladimir Putin during a meeting on development of ‘new regions’, annexed from Ukraine, at the Kremlin, June 30, 2025, in Moscow, Russia. Contributor | Getty Images Russia is set to hike taxes on businesses and consumers as the government looks for ways to support military spending while its war-focused economy creaks at the […]
Read More
Stocks making the biggest moves premarket: Occidental Petroleum, Lithium Americas, Fair Isaac & more
Check out the companies making the biggest moves premarket: Occidental Petroleum , Berkshire Hathaway — Occidental gained around 1% after Berkshire Hathaway announced it was buying the oil company’s petrochemical division, OxyChem, for nearly $10 billion in cash . Class B shares of Berkshire Hathaway slipped about 0.2%. Fair Isaac — The stock rallied 19% […]
Read More
Treasury Secretary Bessent says U.S. GDP could take a hit from the government shutdown
Treasury Secretary Scott Bessent told CNBC’s on Thursday that U.S. economic growth could be hurt by the government shutdown. “This isn’t the way to have a discussion, shutting down the government and lowering the GDP,” Bessent said during a “Squawk Box” interview. “We could see a hit to the GDP, a hit to growth and […]
Read More
CNBC’s Inside India newsletter: India’s gigawatt gold rush
A Nvidia HGX H100 server at the Yotta Data Services Pvt. data center in Navi Mumbai, India, on Thursday, Mar. 14, 2024. Bloomberg | Bloomberg | Getty Images This report is from this week’s CNBC’s “Inside India” newsletter, which brings you timely, insightful news and market commentary on the emerging powerhouse. Subscribe here. The big story […]
Read More
Ultra-wealthy millennials and Gen Zers to displace baby boomers by 2040
Young cheerful lady enjoying on poolside. Resting in spa hotel in pine forest in summertime. Swimming pool in tourist resort. Joyful woman on vacations, female wellbeing. Oleg Breslavtsev | Moment | Getty Images A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor […]
Read More
Berkshire Hathaway to buy Occidental’s OxyChem for $9.7 billion, in Buffett’s biggest deal in three years
Warren Buffett speaks during the Berkshire Hathaway Annual Shareholders Meeting in Omaha, Nebraska on May 3, 2025. CNBC Warren Buffett’s Berkshire Hathaway announced Thursday it reached a deal to buy Occidental Petroleum’s petrochemical unit, OxyChem, for $9.7 billion in cash. The deal marks Berkshire’s largest since 2022, when it paid $11.6 billion for insurer Alleghany. […]
Read More
Forget Trump’s tariffs — here’s what is separating pharma’s winners and losers
The pharmaceutical industry has been making headlines recently, after the administration of U.S. President Donald Trump slapped 100% tariffs on branded and patented drugs But investors say drugmakers’ carve-out agreements on pricing is what will rattle the sector — and create a range of winners and losers as a result. Global pharmaceutical companies who have broken […]
Read More